MedTrace Logo

Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

NCT00190034 · Status: SUSPENDED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2009-02-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether N-acetylcysteine is effective in the prophylaxis of post-cardiopulmonary bypass acute renal impairment.

Conditions

Interventions

DRUG

N-Acetylcysteine 600mg/tab

Sponsors & Collaborators

  • Synmosa Biopharma Corp.

    collaborator INDUSTRY

  • Far Eastern Memorial Hospital

    lead OTHER

Principal Investigators

  • Shao-jung Li, M.D. · Far Eastern Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2007-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00190034 on ClinicalTrials.gov